INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

19,215 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$2.96M
48.6K sh
Jun 1, 2026
Page 229 of 481
← PrevNext →
Jun 3, 2026
traded Jun 1, 2026
+2d
SEC Form 4

Evidence

19
MK
McLaughlin KyleEVP, Aviation
YOUClear Secure, Inc.
Open-market sale · 10b5-1 plan
SELL$450K
8,000 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

17
RS
Radhakrishnan SrikanthChief Science &Techn. Officer
LUNGPulmonx Corp
Open-market sale
SELL$9,192
5,969 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

17
KJ
Kim Peter Sung-JipSVP & GM Industrial Business
LFUSLITTELFUSE INC /DE
Open-market sale
SELL$39K
81 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

17
RS
Radhakrishnan SrikanthChief Science &Techn. Officer
LUNGPulmonx Corp
Open-market sale
SELL$5,673
3,684 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

17
RS
Radhakrishnan SrikanthChief Science &Techn. Officer
LUNGPulmonx Corp
Open-market sale
SELL$4,144
2,691 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

17
RS
Radhakrishnan SrikanthChief Science &Techn. Officer
LUNGPulmonx Corp
Open-market sale
SELL$3,316
2,153 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

16
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$345K
5,600 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

15
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$42K
1,600 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

14
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$2.38M
28.3K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

14
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$6.16M
72.7K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

14
DZ
Daye Wilfred ZhongKeiDirector, CSO
CDChaince Digital Holdings Inc.
Open-market sale
SELL$18K
2,000 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

14
DZ
Daye Wilfred ZhongKeiDirector, CSO
CDChaince Digital Holdings Inc.
Open-market sale
SELL$17K
2,000 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

14
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$4.09M
47.6K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

13
WM
Wittmann MichaelChief Operating Officer
INDIindie Semiconductor, Inc.
Open-market sale · 10b5-1 plan
SELL$66K
12.8K sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

13
SH
Sehmi HarminderChief Financial Officer
BZAIBlaize Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$74K
40.6K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

13
SE
Schubach Sarah ElizabethChief Accounting Officer
DBXDROPBOX, INC.
Open-market sale · 10b5-1 plan
SELL$36K
1,305 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

13
WM
Wittmann MichaelChief Operating Officer
INDIindie Semiconductor, Inc.
Open-market sale · 10b5-1 plan
SELL$127K
24.7K sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

13
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$49K
1,850 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

10
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$1.84M
22.2K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

10
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$1.83M
22.2K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

9
LC
Llewellyn Lindsay CatherineSEE REMARKS
LYFTLyft, Inc.
Open-market sale · 10b5-1 plan
SELL$172K
11.5K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

9
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$392K
1,802 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

8
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$413K
6,853 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

8
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$37K
10.0K sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

8
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$842K
14.3K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

8
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$20K
5,582 sh
Jun 3, 2026Jun 3, 2026
traded Jun 3, 2026
+0dSEC Form 4

Evidence

7
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$331K
4,155 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

7
MA
Misra AmitabhChief Technology Officer
CXMSprinklr, Inc.
Open-market sale · 10b5-1 plan
SELL$267K
45.1K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

6
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$126K
572 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

6
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$90K
413 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

5
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$246K
4,258 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

4
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$157K
1,938 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

4
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$335K
4,246 sh
Jun 3, 2026Jun 3, 2026
traded Jun 3, 2026
+0dSEC Form 4

Evidence

4
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$450K
5,655 sh
Jun 3, 2026Jun 3, 2026
traded Jun 3, 2026
+0dSEC Form 4

Evidence

4
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$821K
9,986 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

3
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$47K
213 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

2
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Open-market sale · 10b5-1 plan
SELL$8,236
146 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

1
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$132K
1,700 sh
Jun 3, 2026Jun 3, 2026
traded Jun 3, 2026
+0dSEC Form 4

Evidence

1
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$23K
262 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence